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With the emergence of numerous brain computer interfaces (BCI), their form factors,
and clinical applications the terminology to describe their clinical deployment and the
associated risk has been vague. The terms “minimally invasive” or “non-invasive” have
been commonly used, but the risk can vary widely based on the form factor and anatomic
location. Thus, taken together, there needs to be a terminology that best accommodates
the surgical footprint of a BCI and their attendant risks. This work presents a semantic
framework that describes the BCI from a procedural standpoint and its attendant
clinical risk profile. We propose extending the common invasive/non-invasive distinction
for BCI systems to accommodate three categories in which the BCI anatomically
interfaces with the patient and whether or not a surgical procedure is required
for deployment: (1) Non-invasive—BCI components do not penetrate the body, (2)
Embedded—components are penetrative, but not deeper than the inner table of the
skull, and (3) Intracranial –components are located within the inner table of the skull and
possibly within the brain volume. Each class has a separate risk profile that should be
considered when being applied to a given clinical population. Optimally, balancing this risk
profile with clinical need provides the most ethical deployment of these emerging classes
of devices. As BCIs gain larger adoption, and terminology becomes standardized, having
an improved, more precise language will better serve clinicians, patients, and consumers
in discussing these technologies, particularly within the context of surgical procedures.
Keywords: brain computer interface (BCI), neuroprosthetic, surgical risk, terminology, ECOG, single neuron, local
field potential, EEG

INTRODUCTION
Brain Computer Interfaces (BCIs) continue to expand in their potential for impact. In its most
simplistic form, a BCI is a computing device that supplants or augments the input and/or output
of the nervous system. Historically, the classical application is to bypass a deficit by establishing
“a communication system in which messages or commands do not pass through the brain normal
output pathways of peripheral nerves and muscles” (Wolpaw et al., 2000). More recently, BCIs
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surgery to implant the necessary sensors, whereas non-invasive
BCIs do not.” However, they also noted that while “invasive”
and “noninvasive” are most often used, other terms such as
“intracranial” and “implanted” have also been interchangeably
used (i.e., in lieu of “invasive”). While the invasive/non-invasive
categorical distinction is widely used, the fact remains that
there is still no unified consensus on the use of this or other
terminology—particularly in a manner that conveys degree of
clinical risk to a user for BCIs that require a surgical procedure.
The BNCI Horizon 2020 initiative built upon the FutureBNCI effort and sought to develop a roadmap for the BCI field
and applications and outline the future of BCIs through 2020
and beyond (Allison et al., 2010; Brunner et al., 2015). This
working group reinforced the key distinction between invasive
and non-invasive BCIs with respect to the presence or absence of
a surgical procedure. Of additional relevance to the present work
is the BNCI working group’s observation that invasive and noninvasive BCIs offer different solutions for different users, which
we discuss further in the context of matching a BCI device to the
clinical indication and balancing clinical risk with user need.
The IEEE SA Industry Connections working group recently
released a BCI Standards Roadmap report, which includes a
summary of various relevant standardization efforts (IEEE SA
Industry Connections No. IC17-007, 2020). The working group
identified that “there is a clear lack of standards and agreed
practices for the terminology used to specify BMI systems” and
that resolving this is an area of high priority for standards
initiatives. Of note, IEEE Working Group P2731 has recently
been established to create a standard for the Unified Terminology
for Brain-Computer Interfaces.
We see the subject matter of our work as complementary
to these and other standardization and road-mapping efforts.
It represents our attempt to offer a semantic framework that is
specifically relevant to the problem of conveying relative risk
for BCIs that require surgical deployment and which may be
helpful in the creation of BCI terminology standards. We must
emphasize that the purpose of this paper is not to present
a comprehensive review of contemporary BCI platforms or
their performance characteristics, which has been extensively
addressed elsewhere, including within the aforementioned
roadmap reports. Further, the focus of this paper is limited
primarily to BCI platforms that require a surgical procedure for
deployment. As BCIs requiring surgical deployment gain larger
adoption, having a more precise terminology to describe these
systems will better serve clinicians, patients, and consumers in
discussing these technologies and trade-offs between user need,
information provided by the BCI, and clinical risk factors.

have been applied to augment existing neural functionality for
improved performance in healthy humans (Arico et al., 2018).
For clinical applications of BCI technology, the diversity of
form factors to meet different clinical indications and surgical
considerations require careful consideration with regard to their
description of risk and deployment. A key distinction is whether
or not a BCI requires a surgical procedure for deployment or
removal. Technologies that require surgical procedures are often
described as “invasive” whereas those that do not require a
surgical procedure are considered “non-invasive” (Allison et al.,
2010). It may be unclear, however, how “invasive” should be
interpreted from a risk standpoint, particularly when using terms
that convey a gradation of invasiveness.
In recent years, the terms “minimally invasive” and “minutely
invasive” have been used to describe emerging and prospective
categories of invasive neural interface devices. Minimally invasive
typically characterizes devices that require a surgical procedure
but have a low risk of infection or where contact or disruption
of neural tissue and vasculature is minimal (Hochberg and
Donoghue, 2006). This includes surgical procedures with a
small footprint (e.g., a minor incision) and/or which may be
distal to the brain (e.g., intracranial electrode delivery via an
endovascular stent or a lumbar puncture). Minutely invasive is a
term recently introduced by the United States Defense Advanced
Research Projects Agency (DARPA) which characterizes a class of
prospective devices that could be introduced to the brain without
a surgical procedure (e.g., nano-scale devices that could be
delivered to the brain through intravenous injection, ingestion,
insufflation, or other non-surgical methods) (DARPA, 2019).
However, while these terms are usually intended to convey
gradations of surgical risk, a significant level of ambiguity
remains regarding the appropriate definition and application of
these terms. For instance, describing a procedure as minimally
invasive may carry very distinct surgical morbidities. The
imprecise language as it relates to invasiveness and risk may deter
or otherwise influence decision making as to whether a device is
appropriate for the given indication. This precision is important
when the indication can range from a quadriplegic patient to a
healthy consumer.
In this work we will briefly describe the major current
and emerging BCI platforms with an emphasis on those
requiring a surgical procedure, define risk profiles, and propose
a terminology structure that we believe enables a more accurate
and informative description of the invasiveness and clinical risk
for BCIs that require surgical deployment.
There are several past and ongoing projects focused on the
characterization and/or standardization of BCI platforms and
their applications, including standardizing certain aspects of the
BCI terminology. These projects include the Future Brain-Neural
Computer Interface (Future-BNCI) and BNCI Horizon 2020
Initiatives, initiated by the European Commission in 2010 and
2013, respectively. Amongst its four major goals, the FutureBNCI project sought to establish clear standardized terminology
for BCIs, emphasizing that “terms and definitions do matter”
(Allison et al., 2010; Future BNCI Project, 2012). The initiative
presented a clear distinction between “invasive” and “noninvasive” BCIs, with the definition that “invasive BCIs require
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DEFINING A BRAIN COMPUTER
INTERFACE
The goal of a BCI is to restore or to augment neural
functions by interfacing a computing device with the nervous
system. A contemporary understanding of a BCI is “a system
that measures central nervous system (CNS) activity and
converts it into artificial output that replaces, restores, enhances,
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supplements, or improves natural CNS output and thereby
changes the ongoing interactions between the CNS and its
external or internal environment” (Wolpaw and Wolpaw,
2012). The source of signals used as input to the device can
range from individual neuronal action potentials to electric
or magnetic field potentials from larger cortical ensembles
to hemodynamic changes associated with neuronal activity.
Relevant signal features can include neuronal firing rate, quasioscillatory coherent activity in cortical ensembles, event-related
potentials, functional connectivity, or changes in blood oxygen
concentration, to name a few. Output effectors are also wideranging. Examples include computer cursor movement or object
selection, robotic arm control, re-animation of paretic limbs, and
synthesized language, amongst other applications. In contrast
to control or communication, the output of a BCI may also
be used to unobtrusively monitor a user’s cognitive or affective
states, such as attention, cognitive load, or emotional states,
without requiring the user to consciously control or direct the
BCI. The terms active and passive BCIs have been introduced to
differentiate between these respective types of systems (Zander
and Kothe, 2011).
By reversing the direction of information transfer from an
output device, one can similarly develop an input device. In this
scenario the device input is typically an electromagnetic stimulus
delivered to the brain that modulates neuronal activity, thereby
converting external information (e.g., light or sound) into an
artificial sensation or perception (Normann et al., 2009; Liao
et al., 2012; Gaylor et al., 2013). Alternatively, the input stimulus
may be used to alter the neural system dynamics to change
a cognitive state (e.g., enhance mood or attention). Input and
output BCIs can be combined, such that they are “closed loop.”
An example of this could be haptic input from sensors in the
robotic arm of a prosthesis for tactile or proprioceptive feedback
(O’Doherty et al., 2011; Flesher et al., 2016). BCIs may also be
broadly characterized by their type of operation (e.g., motor,
somatosensory, speech, auditory) and their neural interface
modality (e.g., single unit neuron, electroencephalography, near
infrared, etc.).
In considering invasiveness and the attendant risks associated
with the interface, this relies heavily on how the system
physically interfaces with the patient. Thus, anatomic location
requires special consideration. To this end we will briefly
highlight exemplars of the different BCI platforms through
this anatomic lens. Figure 1 presents a graphical summary
of several of these systems. Table 1 summarizes additional
characteristics, development stage, current/near-term user
groups, presence/absence of catastrophic risk in deployment,
and normative categorization of each system using the extended
terminology proposed in this paper. For a more comprehensive
examination of existing BCI platforms and their characteristics,
we refer the reader to the following resources (Allison et al.,
2010; Wolpaw and Wolpaw, 2012; Brunner et al., 2015; IEEE
SA Industry Connections No. IC17-007, 2020). Additionally, for
a detailed review of non-invasive EEG BCI systems and their
current and anticipated applications, we refer the reader to a
three-part series of articles published in the Special Centennial
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FIGURE 1 | Anatomic locations of representative BCI sensors. BCI form
factors have sensors in a diverse number of anatomic locations. Some are on
or above the surface of the scalp (near infrared, EEG, and MEG) the others
penetrate the body to varying degrees. EEG, electroencephalography; NIR,
near infrared; ECoG, electrocorticography; LFP, local field potential.

Issue of the Proceedings of the IEEE (Lance et al., 2012; Liao
et al., 2012; Makeig et al., 2012).

Electroencephalography (EEG) BCI
Systems
These are BCI systems that have electrodes on the scalp
which measure electric field potentials over centimeters of
cortex. Due to signal transformations by the skull and
scalp, EEG BCI systems are predominantly constrained to
relatively high amplitude, lower-frequency brain rhythms
(<90 Hz). EEG BCIs have increasingly found practical utility
for passive monitoring of a wide variety of brain states
(Lance et al., 2012) and for communication by tracking
attention allocation and enabling control systems with 2–3
degrees of freedom (Wolpaw and McFarland, 2004; Fazel-Rezai
et al., 2012; Bundy and Leuthardt, 2014). Scalp electrodes
can also be used to transcranially deliver electrical current
to the brain, allowing for some input control over neural
activity (Paulus, 2011; Kuo and Nitsche, 2012). The low cost,
low risk, maturity, and increasing wearability and diversity
of applications of EEG BCI systems have led to significant
adoption in both consumer and clinical applications, as well
as research applications (Machado et al., 2010; Lance et al.,
2012).
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TABLE 1 | Representative current and emerging BCI systems.
BCI modality

Output/Input

Development
stage

Current and near-term
user groups

Deployment
catastrophic risk

Normative categorization

Electroencephalography (EEG)

Output, Input

In use

Healthy users, patients,
researchers

Absent

Non-invasive

Magnetoencephalography (MEG)

Output

In use

Healthy users, patients,
researchers

Absent

Non-invasive

Near-Infrared (NIR) optical

Output,
Input†

In use

Healthy users, patients,
researchers

Absent

Non-invasive

Intracalvarial

Output, Input

Early stage

Potential utility for healthy
users, patients,
researchers

Absent

Minimally Invasive,
Embedded

Intravascular

Output, Input

Early stage

Potential utility for
patients, researchers

Present

Minimally Invasive,
Intracranial

Local field potentials (LFPs)

Output, Input

In use

Patients, researchers

Present

Invasive, Intracranial

Microelectrodes for Single and
Multi Unit Activity (SUA, MUA)

Output, Input

In use

Patients, researchers

Present

Invasive, Intracranial

Neural dust

Output, Input

Early stage

Potential utility for
Patients, researchers

Present

(Minimally) Invasive,
Intracranial

Each system’s development stage and current and near-term anticipated user groups are presented, alongside presence/absence of catastrophic risk in deployment and a normative
categorization using the extended terminology proposed in this paper.
†
NIR neuromodulatory effect likely via indirect mechanisms of action.

Magnetoencephalography (MEG) BCI
Systems

2016; Askalsky and Iosifescu, 2019). NIR BCI systems have
demonstrated practical utility for healthy users as well as clinical
and research applications (Naseer and Hong, 2015).

These are output-only BCI systems that measure fluctuations
in magnetic fields with the same etiology as those obtained
from EEG but which are unimpeded by the skull and may
yield additional information regarding specific cortical activity
(Waldert et al., 2008; Malmivuo, 2012; Destoky et al., 2019). The
range of applications of MEG BCIs are historically similar to
that of EEG, and, until recently, MEG BCIs were impractical
due to the high cost and size of such systems. Recent advances
in quantum magnetic field detectors which do not require
superconducting technology and can be embedded in a wearable
form factor is increasing the potential for practical applications
in consumer and clinical sectors (Boto et al., 2018); however,
it remains to be seen whether or how this will impact
BCI applications.

Electrocorticography (ECoG) BCI Systems
These are neural interfaces that measure electric field potentials
from the surface of the cortex with high spatiotemporal
resolution (Leuthardt et al., 2009; Schalk and Leuthardt, 2011).
These systems can be both input and output BCIs and have the
advantage of having access to high-frequency cortical rhythms in
the brain (70–300 Hz) that are associated with highly resolved
information about cognitive intentions (e.g., motor kinematics
and speech articulation) (Leuthardt et al., 2004, 2009; Schalk and
Leuthardt, 2011; Bundy et al., 2016; Anumanchipalli et al., 2019).
Current and near-term applications of ECoG BCI systems are
clinical and research oriented.

Local Field Potentials (LFP) BCI Systems

Near-Infrared (NIR) Optical BCI Systems

LFP BCI systems are not constrained to the cortical surface.
These systems record electric field potentials from cortical
populations within the brain parenchyma itself which includes
cortex or deeper brain structures. Similar to ECoG, they access
a broad frequency spectrum of dynamical brain activity and can
be both output and input BCIs (Wang et al., 2010; Vadera et al.,
2013; Li et al., 2017). Current and near-term applications of LFP
BCI systems are clinical and research oriented.

These are typically output BCI systems that measure nearinfrared light to track hemodynamic activity, such as the
concentration changes of oxygenated hemoglobin (HbO) and
deoxygenated hemoglobin (HbR), as a local signal of brain
activation (Naseer and Hong, 2015) and as inputs to a BCI. The
slow hemodynamic response to transient changes in neuronal
activity imposes constraints on the temporal speed of operation
(Matsuyama et al., 2009) relative to electrical or magnetic sensing
methods. NIR BCI systems also have the potential to function
as input systems, since near-infrared and red light have been
demonstrated to have potential diffuse neuromodulatory effects
when applied transcranially (known as photobiomodulation),
likely through an indirect mitochondrial mechanism of action as
well as potentially via light-sensitive ion channels or activation
of signaling mediators and transcription factors (Hamblin,
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Single Unit and Multi Unit Activity (SUA,
MUA) BCI Systems
These systems have microscale electrodes that are implanted
within the brain parenchyma and record action potentials from
single neurons. There are numerous types of electrode form
factors including silicon (e.g., Utah array), microwires, carbon
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intravascular locations. Complications for an invasive procedure
typically include bleeding, infection, and injury to adjacent
tissues. Complications in the intracranial space, however, can be
substantially different from identical type of complications in
embedded space. As an example, an infection in the intracranial
space (e.g., meningitis, brain abscess) has the potential to be
imminently life threatening and neurologically catastrophic if
not addressed with a neurosurgical intervention and antibiotics.
For an extracranial infection the morbidity is not as high and can
likely be addressed in a less emergent fashion. This also holds
true for other neurosurgical complications, such as postoperative
hemorrhage. Finally, there are some anatomic locations that
have unique risk considerations given their particular anatomic
location. Specifically, intravascular devices, such as stentelectrodes (e.g., the Stentrode) (Oxley et al., 2016) which are
placed in veins and arteries, carry the risk of perforation or
occlusion which can result in a stroke or hemorrhage. While
these catastrophic risks can be kept extremely low, it is important
to recognize their presence, since this can have an impact in
matching the form factor with the given clinical indication.
This matching is essential in determining the ethical balance of
risk vs. benefit, but also plays a role in clinical adoption. Even
if a catastrophic risk is extremely low and the given clinical
indication is appropriate, the very presence of the risk may
impact a patient’s decision to adopt the technology.
The term “minimally invasive” has been used frequently in
describing various platforms and implicitly conflates the level
of clinical risk. As an example, if a device requires a very
small surgical incision that does not necessarily mean that the
procedure is a lower clinical risk. If an intravascular BCI only
requires a vascular access approach (2 mm puncture) is it less
risky than an implantable device that doesn’t penetrate the inner
table of the skull, but has a larger incision? The intravascular
device would carry a risk of stroke (despite the small incision),
whereas a sub-scalp implant with a larger incision would not
carry a concomitant stroke risk. Thus, taken together, there
needs to be a terminology that best accommodates the surgical
footprint of a BCI and the attendant risks with the deployment of
the device.

nanotubes, and flexible polymers (Cogan, 2008). These systems
enable decoding of substantial and highly resolved information
about cognitive operations (e.g., complex motor kinematics) and
can be both input and output BCIs (Taylor et al., 2002; Hochberg
et al., 2006, 2012; Lebedev and Nicolelis, 2006; Hatsopoulos and
Donoghue, 2009; Collinger et al., 2013; Flesher et al., 2016, 2017;
Musk, 2019). Current and near-term applications of these BCI
systems are clinical and research oriented.

Intravascular BCI Systems
Electrode arrays and systems that are placed within the vessels
of the brain (e.g., superior sagittal sinus) to record and stimulate
from adjacent brain parenchyma (e.g., motor cortex) (Watanabe
et al., 2009; Oxley et al., 2016; Forsyth et al., 2019). Current and
near-term applications of intravascular BCI systems are primarily
clinical and research oriented.

Neural Dust
An emerging class of millimeter-sized devices (aimed at <100
µm3 ) operated and wirelessly powered sensors/stimulators which
can be used as an input/output BCI. These systems are
implanted within neural tissue and each neural dust mote
possesses a piezoelectric crystal that can convert mechanical
power from ultrasonic pulses broadcast from outside the body
into electrical power. This power can be used to study, monitor,
or stimulate neural tissue and to remotely monitor neural
activity (Seo et al., 2013, 2015, 2016). These systems are still in
early stages of development for human intracranial use; once
suitably miniaturized, applications will likely be clinical and
research oriented.

Intracalvarial BCI Systems
These are systems that are implanted but preserve the inner
portion of the skull. Because of the close proximity to the
cortical surface, these systems can act as input/output BCIs
with capabilities similar to an ECoG BCI system but without
intracranial penetration (Brodnick et al., 2019). Intracalvarial
BCI systems are still nascent, but have potential applications for
healthy users as well as clinical and research applications.

ANATOMIC CONSIDERATIONS AND
DETERMINATION OF INVASIVENESS

EXTENDED BCI TERMINOLOGY TO
CONVEY ANATOMICAL LOCATION AND
RISK—NON-INVASIVE, EMBEDDED, AND
INTRACRANIAL

The anatomic location of the various sensor modalities plays
a significant role in considering the clinical implications
and risks of the systems. In broad categories, they can be
divided into invasive vs. non-invasive, where “non-invasive”
means that the use of the system does not require procedural
insertion into the body. These types of systems would include
EEG and NIR types of BCIs. Once the body is penetrated,
risk considerations change with anatomic location. The next
significant distinction, which applies to invasive systems, is
intracranial vs. embedded. Embedded form factors include
systems that are implanted in the subcutaneous, subgaleal,
extracalvarial, intracalvarial, or other endo/extracranial spaces.
Intracranial locations include intradural/intraparenchymal,
intradural/extraparenchymal,
extradural/intracranial,
and

Frontiers in Neuroscience | www.frontiersin.org

Considering the arguments put forth in the preceding sections,
we propose the following semantic framework that attempts to
describe the BCI from an anatomical/risk standpoint (Figure 2).

Non-invasive
These are BCI systems, such as EEG, MEG, and optical based
approaches, that may contact the surface of the body but do
not require penetration of the skin. These systems do not have
any procedural risk for infection, or tissue injury. The risk
for a catastrophic life threatening/altering event is absent (i.e.,
catastrophic risk absent).
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systems. Intracranial systems have procedural risk for infection,
hemorrhage, or tissue injury which if this should occur
intracranially could be life threatening and have the possibility
of brain injury (i.e., catastrophic risk present). Here, the terms
minimally invasive and minutely invasive apply for intracranial
systems in the same manner as for embedded systems.
It is important to note that these categories address the
surgical description of risks associated with the placement and
location of the device not only during deployment but also
for surgical revision. If the system fails, becomes infected, or
creates an unwanted tissue response, risk of removal must
be considered. The general stratification of risks is similar as
described above, but it is not an uncommon scenario that a
device is relatively low risk at implantation, but the procedure
for its removal is substantially more risky due to tissue adherence
or need for an alternate surgical approach for explantation.
Here, once again, anatomic location can play a large role. In
particular, it is important to consider the durability risk. Will an
implanted device continue to operate over an extended period
of time? As an example, in the past there have been concerns
that some microelectrodes implanted in the brain may show
degraded ability to record neuronal spiking over a relatively
short period of time due to astrocytic responses including glial
encapsulation around electrodes (Turner et al., 1999; Suner et al.,
2005; Bjornsson et al., 2006; Seymour and Kipke, 2007; Flesher
et al., 2017; Salatino et al., 2017). While more recent studies have
shown improved longevity in small clinical pilots (Simeral et al.,
2011; Hochberg et al., 2012; Gilja et al., 2015), it will be important
that the issue of durability be rigorously defined for widescale
adoption. Frequent replacement of the implant could lead to local
injury and would not be palatable to patients and surgeons. In this
regard, invasive embedded devices (and certainly non-invasive
devices) have a much lower risk than intracranial devices.
While anatomic considerations and their descriptions are
essential for a surgical description of risk, there may also be
contraindications which could increase the level of clinical risk
for a specific BCI system. For instance, a non-invasive BCI that
comes into contact with and applies pressure to the scalp could
present elevated clinical risk to an individual with sensitive skin
or head injury. Certain BCI system inputs could also increase
risk due to underlying neurological conditions; for instance,
commonly used SSVEP or P300 BCIs that present flickering
stimuli may induce seizures in individuals with photosensitive
epilepsy. While a thorough discussion of these and other risk
factors is beyond the scope of this paper, we refer the reader
to existing reports which comprehensively address this topic
(Future BNCI Project, 2012; IEEE SA Industry Connections No.
IC17-007, 2020).

FIGURE 2 | Proposed terminology for BCI systems and schematic of
matching the device with the indication. (A) Non-invasive. BCI systems, such
as EEG and optical based approaches, that may touch the surface of the body
but do not require penetration of the skin. No surgical procedure is required.
Embedded. BCI systems that generally require a surgical procedure for
placement, but do not enter the intracranial space. These include devices that
are within the scalp, beneath the galea, or within the skull (but not through the
inner table). Intracranial. BCI systems that are intracranial in location and
generally require a surgical procedure for placement. These include ECoG,
multi-electrode arrays, neural dust, and intravascular electrode systems. (B)
The three driving factors that influence a BCI application are clinical need,
clinical risk of the device, and neurologic information necessary to support the
BCI solution. Various clinical scenarios have distinct informational demands
and risk tolerance. (C) Represents “high need—high risk” clinical indication,
such as a quadriplegic patient, who has a substantial clinical need for neural
restoration to improve his/her quality of life and a higher risk can be tolerated
ethically. (D) Represents “low need—low risk” scenario where a neural
interface is used for cognitive augmentation but given the low clinical need
would require a lower risk to be ethically feasible. (E) Imbalanced scenario
where information and risk are excessive to clinical need of the device.

Embedded
These are invasive BCI systems that require a surgical procedure
for placement, but do not enter the intracranial space. These
include devices that are within the scalp, beneath the galea, or
within the skull (but not through the inner table). If the device
requires a surgical incision less than ∼1 cm the embedded system
is minimally invasive. These systems have procedural risk for
infection or tissue injury but are not life threatening nor do
they carry the risk of significant morbidity (i.e., catastrophic
risk absent). If the system can be placed in the absence of
surgical approach, we refer to the system as a minutely invasive
embedded system. Minutely invasive embedded devices may
require nanoscale techniques for deployment.

MATCHING THE DEVICE WITH THE
INDICATION

Intracranial

With the myriad form factors, anatomic locations, and potential
applications of invasive BCIs, it is worth considering some
general principles for how to consider a BCI and patient
indication. The three driving factors that influence an invasive

These are invasive BCI systems that are intracranial in location
and require a surgical procedure for placement. These include
ECoG, LFPs, single units, neural dust, and intravascular electrode

Frontiers in Neuroscience | www.frontiersin.org
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BCI application are (1) clinical need, (2) clinical risk of
the device, and (3) neurologic information necessary to
support the BCI solution. These interactions and clinical
examples are highlighted in Figure 2. It is important to note
that the following examples are hypothetical scenarios and
do not represent the current state of technology readiness,
but rather form factors and applications that emphasize
these principles.
One scenario is the “high need—high risk” clinical indication
(Figure 2B). As an example, a quadriplegic patient has a
substantial clinical need for neural restoration to improve
his/her quality of life. A robust system that could enable
this type of patient to meaningfully communicate with
and engage their environment (e.g., a robotic exoskeleton
for walking or robotic limb capable of self-feeding) would
produce substantial value to the patient. However, it would
also require highly resolved information of neural intentions.
Typically, higher levels of information frequently require
closer proximity and more sensitive interactions with
neurons and neural tissue. Put another way, increases in
neural information often are parallel with the degree of
invasiveness (and associated risk). In the case of a quadriplegic
patient, the risk of intracranial implantation is justified to
acquire the level of neural information and meaningful
functional improvement.
A different example is “low need—low risk” scenario
(Figure 2C) where a neural interface is used for cognitive
augmentation. Essentially, a device that is enhancing neurological
function beyond the normal baseline of the user. While there may
be a strong demand for the technology, this “cosmetic” approach
does not have a strong clinical need. Thus, the associated
risk of the interface should also be low. In this case, it may
not be appropriate to have an intracranial implant like one
used in a quadriplegic patient where the risk of catastrophic
adverse event is possible. The neurologic information and
risk would be excessive relative to the intended indication
(Figure 2D).
Invasive and non-invasive BCI systems convey different
amounts of neural information relevant to a BCI. While the
origin of activity measured by similar modality non-invasive
and invasive BCIs is ostensibly the same (e.g., electrical activity
measured by invasive and non-invasive BCIs originate primarily
from (presynaptic) action potentials in cortical layers 1–4), noninvasive BCIs measure variants of etiologic signals which are
transformed in ways that are not fully understood or may not
be “reversable,” thus resulting in varying degrees of reduced
information transfer relative to invasive BCI systems (Steyrl
et al., 2016). In some cases, this may have little impact on
BCI performance or reliability, while in other cases it can
have significant effects. For instance, hand movement direction
decoding accuracy and decoded information (in bits) increases
progressively from EEG to MEG to ECoG to LFP to SUA
(Waldert et al., 2008). While it is conceivable that future advances
in physics, sensor technology, and signal processing could
reverse these signal transformations, yielding an equivalence
in the information conveyed by non-invasive and invasive
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BCIs, the field is not yet there. The cranial bone and skin
tissue are primary sources of this signal transformation and
associated information reduction. As such, when progressing
from non-invasive, to embedded, to intracranial BCIs we
may expect an increase in information conveyed by the
system. Concomitant with this progression is an increase in
clinical risk, albeit not necessarily in the same proportion.
The relative degree of these two factors (information/risk),
along with user need, should inform the decision as to
whether or not a specific BCI system is appropriate in each
particular situation.
The aspirational scenario is an extremely high degree of
neurological information with minimal clinical risk that can
be deployed across all types of need scenarios. The field is
not there yet, thus a balanced approach is required when
considering clinical deployment. It is important to note that
the risk balance can change with time and experience. Over
time, if an intracranial implant used for a high clinical need
scenario has demonstrated extremely low risk experience, it can
be applied to lower need-based applications. This is likely a
scenario that will emerge where neural interfaces will transition
from neuro-restorative approaches to those that are more focused
on neural augmentation.
In addition to the appropriate balance of risk and benefit,
which often guides the neurosurgeon decision to pursue an
intervention, appropriately defining end-user preferences is a
critical consideration both for the design and implementation
of any BCI technology, but also for the success or failure of
its adoption. The user may have needs and preferences for the
interaction with the technology that may be distinct from the
risk-benefit calculation (Lahr et al., 2015). Blabe et al. highlights
this in a large survey of spinal cord injury patients (Blabe et al.,
2015). Here they find that patients would prefer an unobtrusive,
autonomous BCI system for both restoration of upper extremity
function and control of external devices such as communication
interfaces, even if the device is more invasive and higher risk
than one that is aesthetically unpleasing, unreliable, or difficult
or embarrassing to use. Some of these trade-offs currently are still
hypothetical in that current invasive devices are not unobtrusive
but may be in the future. While a detailed examination of user
experience factors in BCI design is outside the scope of this
paper, we refer the reader to two papers (Huggins et al., 2011;
van de Laar et al., 2012) which address these factors, as well as
aforementioned Future BNCI and IEEE BCI Roadmap reports.

CONCLUSION
BCI form factors require a more precise language to categorize
their surgical impact and risk. The commonly used two-class
terminology that distinguishes between “non-invasive” (nonsurgical) and “invasive” (surgical) BCIs carries significant
ambiguity with respect to the surgical footprint of a BCI
and the attendant risks with the deployment. We propose
that having more anatomically specific descriptions—“Noninvasive,” “Embedded,” and “Intracranial”—with defined
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